Kyle Gano, Chief Business Development Off: Neurocrine Biosciences NBIX Sell · Filed 23/02/08

Trade details

Type: Insider sale
Amount: $1,310,950.41
Shares · price: 12,801 sh · $102.41 a share
Held after: 127,216 sh
Stock: Neurocrine Biosciences NBIX
Person: Kyle GanoChief Business Development Off
Trade date: 23/02/07
Filed: 23/02/08
Days to filing: 1 days

Sold 9.1% of holdings

Share of holding sold: 9.1%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/01/08~23/03/09

Kyle Gano's recent trades

Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$4.6M
34,588 sh
$4.6M
Filed 01/20
Traded 01/16
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$240.5K
1,812 sh
$240.5K
Filed 01/20
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$4.9M
36,400 sh
$4.9M
Filed 01/16
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/05
Traded 25/11/04
Kyle GanoCEO
SellNeurocrine Biosciences
Sell
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/04
Traded 25/11/04